Ag. Clark et al., Serum cartilage oligomeric matrix protein reflects osteoarthritis presenceand severity - The Johnston county osteoarthritis project, ARTH RHEUM, 42(11), 1999, pp. 2356-2364
Objective. To characterize serum cartilage oligomeric matrix protein (COMP)
levels by age and gender for a radiographically defined population free of
hip and knee osteoarthritis (OA), and to examine the potential utility of
COMP as a diagnostic biomarker for knee OA.
Methods. Serum samples and knee and hip radiographs were obtained at a base
line evaluation as part of the Johnston County Osteoarthritis Project, a po
pulation-based study of OA in rural North Carolina. A total of 291 Caucasia
n participants were randomly selected for COMP analysis, 143 patients with
radiographic knee OA (Kellgren/Lawrence [K/L] grade greater than or equal t
o 2) and 148 controls with neither hip nor knee OA (KIL grade 0), evenly di
stributed by age and gender. COMP was quantified by competitive enzyme-link
ed immunosorbent assay with monoclonal antibody 17-C10, The natural log-tra
nsformed COMP data were analyzed using general linear models.
Results, Serum COMP levels were significantly elevated (P = 0.0001) in the
age greater than or equal to 65 group (mean +/- SD 1,302.1 +/- 496.7 ng/ml)
versus the age 45-54 and age 55-64 groups (1,058.1 +/- 432.4 and 1,038.6 /- 313,3, respectively), Serum COMP levels of the OA group were significant
ly higher than those of the control group (1,208.57 +/- 487.37 ng/ml versus
1,061.83 +/- 370.58 ng/ml; P = 0.0093, Serum COMP levels also increased si
gnificantly with knee OA K/L grade (P = 0.0047), knee OA laterality (P = 0.
0043), and number of knee and hip joints involved (P = 0.0001), There was n
o significant difference in serum COMP levels by gender or obesity.
Conclusion. We demonstrate that in a population-based sample, serum COMP le
, els can distinguish an OA-affected subgroup from an unaffected subgroup a
nd can reflect disease severity and multiple joint involvement in OA.